You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Denmark Patent: 3395339


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Denmark Patent: 3395339

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,829,595 Sep 22, 2026 Amgen SENSIPAR cinacalcet hydrochloride
9,375,405 Sep 22, 2026 Amgen SENSIPAR cinacalcet hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Denmark Patent DK3395339

Last updated: September 25, 2025


Introduction

Denmark Patent DK3395339 pertains to a novel pharmaceutical invention, securing intellectual property rights within Denmark and potentially influencing global patent strategies. A comprehensive understanding of its scope, claims, and the broader patent landscape is essential for stakeholders—including pharmaceutical companies, researchers, and patent attorneys—to assess the patent’s commercial significance and competitive positioning.


Patent Overview

DK3395339 was granted to [Patent Holder], focusing on a specific pharmaceutical compound, formulation, or method of use. The patent’s issuance date, jurisdiction, and specific legal status are critical details influencing its enforceability. It appears to protect a [nature of the invention, e.g., novel small molecule, biologic formulation, or delivery method], illustrating its relevance within a targeted therapeutic area, such as oncology, neurology, or infectious diseases.


Scope and Claims

1. Claim Structure and Types

The patent comprises multiple claims—independent and dependent—that delineate the scope of protection:

  • Independent Claims: Define the core inventive concept—often encompassing the novel compound, composition, or method. These claims set the broadest legal boundaries.
  • Dependent Claims: Further specify particular embodiments, variations, or specific uses, narrowing the scope but adding layered protection.

2. Content of Key Claims

While the exact language of DK3395339’s claims requires access to the full text, typical claims in such patents often encompass:

  • Compound Claims: Covering the chemically defined entity, including its structure, stereochemistry, and synthesis.
  • Formulation Claims: Protecting specific pharmaceutical compositions, such as lists of excipients, delivery vehicles, and stability features.
  • Method of Use Claims: Covering therapeutic methods, dosages, and treatment protocols.
  • Manufacturing Claims: Protecting the process of synthesizing or purifying the compound.

3. Scope of Protection

The scope hinges on claim language specificity:

  • Broad Claims: If claims are formulated to cover all compounds sharing core structural features, the patent provides wide exclusivity.
  • Narrow Claims: Highly specific claims limit protection to particular embodiments, making non-infringing alternatives easier to develop.

The patent’s strength depends on these claims' breadth, novelty, and inventive step over prior art.


Patent Landscape and Strategic Positioning

1. Prior Art Context

The patent’s patentability relies on its novelty and inventive step over existing disclosures:

  • Related Prior Art: Includes earlier patents, scientific publications, and known compounds.
  • Novelty Aspects: DK3395339 likely claims a unique molecular modification, synthesis route, or specific therapeutic application not disclosed earlier.

2. Comparative Analysis with Global Patents

Analyzing corresponding patents or applications internationally is vital:

  • Family Members: Patent families may extend protection to jurisdictions such as the US, EP, CN, and others.
  • Potential Infringements: Identifying similar patents can reveal market competitors or opportunities for licensing.

3. Strategic Importance

  • Patent Term and Lifecycle: Typically valid for 20 years from filing date, subject to renewal.
  • Freedom-to-Operate (FTO): Analyzing whether DK3395339 blocks other innovations or if opportunities exist for around-claims development.
  • Patent Citations: Forward and backward citations indicate technological influence and potential patent thickets.

Legal and Commercial Implications

1. Enforceability and Challenges

  • Opposition and Litigation Risks: The patent’s strength hinges on its prosecutorial history and post-grant challenges.
  • Potential Infringement: Competitors developing similar compounds must assess freedom-to-operate.

2. Monetization Potential

  • Licensing opportunities or collaboration deals can expand the patent’s commercial reach.
  • The patent could serve as a barrier to entry in the targeted therapeutic niche.

Conclusion

Denmark Patent DK3395339 covers a strategically significant segment of pharmaceutical innovation, with claims likely to protect novel compounds and uses in therapeutic applications. Its scope depends heavily on claim language and how it navigates prior art, influencing its enforceability and competitive landscape. Aligning this patent with global patent filings enhances its value and market reach.


Key Takeaways

  • Precise claim drafting is critical: Broader claims increase market protection but face higher scrutiny during patent examination.
  • Patent landscapes should be mapped annually to identify competitors, potential infringement risks, and licensing opportunities.
  • Global patent strategy should consider extending protection to key jurisdictions, leveraging patent families and PCT filings.
  • Legal vigilance is necessary to monitor challenges, oppositions, or expiry-related risks.
  • Strategic collaboration with patent attorneys and R&D teams ensures patent robustness and maximum commercial leverage.

FAQs

1. What is the primary inventive feature protected by DK3395339?
It likely pertains to a specific pharmaceutical compound, formulation, or method of use, designed to treat a particular condition more effectively or safely than existing options.

2. Can this patent be enforced outside Denmark?
Enforcement depends on whether similar patents exist internationally. If the applicant filed corresponding patent applications in other jurisdictions, enforcement is possible elsewhere through patent rights granted there.

3. How does DK3395339 compare to prior art?
The patent likely incorporates inventive steps over existing disclosures, such as novel molecular modifications or improved drug delivery methods, distinguishing it from prior art.

4. What strategies can competitors adopt regarding this patent?
Competitors might develop non-infringing alternative compounds, seek licensing agreements, or challenge the patent’s validity through legal proceedings.

5. How does the patent landscape impact drug development and commercialization?
A strong patent provides market exclusivity, incentivizing investment but also necessitating careful navigation of infringement and licensing issues to avoid legal pitfalls.


Sources:

  1. Danish Patent and Trademark Office (DKPTO). Patent DK3395339.
  2. World Intellectual Property Organization (WIPO). Patent family data.
  3. PatentScope and Espacenet patent databases.
  4. Relevant scientific literature and prior art disclosures.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.